-
Patients with abnormal thyroid function of "new crown infection", why are other thyroid tests okay
Time of Update: 2023-02-03
Long-term four-dose insulin intensive blood sugar control before admission, after admission, due to five abnormalities of thyroid function, please consult with our department: case two, a 16-year-old woman, admitted to the hospital due to "polydipsia, polydipsia, weight loss for more than 4 years, fever with change in consciousness for 1 hour", considered for diagnosis: type 1 diabetes, diabetic ketoacidosis; Fever investigation: novel coronavirus infection?
-
Genting Xinyao announces that the new mRNA rabies vaccination project has successfully reached its preclinical milestone
Time of Update: 2022-12-30
HKEX 1952. HK, a biopharmaceutical company focused on the development and commercialization of innovative drugs to address unmet medical needs in Greater China and other Asian regions, today announce
-
Sex Transm Infect: A modified rapid diagnostic test to detect syphilis and yaws
Time of Update: 2022-10-31
Table 1 Summary of studies included in meta-analysis (n=17)Figure 1 Forest plot of sensitivity and specificity of Treponema pallidum.
Table 1 Summary of studies included in meta-analysis (n=17)Figure 1 Forest plot of sensitivity and specificity of Treponema pallidum.
-
Immunity Reveals Antitumor Mechanism of Tertiary Lymphoid Structure in Renal Cell Carcinoma Using 10x Genomics Visium FFPE Spatial Transcriptome Technology
Time of Update: 2022-04-26
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer, using 10x Genomics Visium FFPE spatial transcriptome technology to discover Tertiary lymphoid structures (TLS) in renal cell carcinoma are important sites for B cell maturation and differentiation into plasma cells (also called effector B cells), and IgG+ plasma cells are associated with immune checkpoint inhibitor treatment response and progression-free survival in patients showing a positive correlation .
-
The Pasteur Institute of France has discovered the closest coronavirus to the new coronavirus in Laos
Time of Update: 2021-09-29
Coronaviruses with a SARS-CoV-2-like receptor-binding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula, DOI: 10.
Reference: Coronaviruses with a SARS-CoV-2-like receptor-binding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula, DOI: 10.
-
Pfizer vaccine can neutralize new mutations of new coronavirus
Time of Update: 2021-06-22
With the emergence of new variants of the new coronavirus, it is urgent to evaluate the immune effects of existing vaccines to produce antibodies and neutralize these variants .
Use BNT162b2 immune serum to neutralize the new coronavirus mutant strain .
-
Lancet: IL-17A/F Nanobody Solomizumab has been successfully treated in Phase II clinical trial of plaque psoriasis
Time of Update: 2021-05-08
Patients aged 18-75 with moderate to severe plaque psoriasis participated in the study and were randomly divided into 6 groups, namely placebo group, 30 mg solovizumab group, 60 mg solovizumab group, Solocizumab 120 mg normal load group, solocizumab 120 mg enhanced load group or secukinumab 300 mg group.
-
Nature: Scientists are calling for vaccines to be developed to prevent future outbreaks
Time of Update: 2021-02-27
Denis Burton and Eric Topol of Scripps Research, wrote an opinion article in the journal Nature, calling on the government to provide substantial financial support for reasonable vaccine design based on broad-based and antibodies.
-
The team of the Chinese Academy of Sciences has developed therapeutic antibodies for new coronary pneumonia into clinical trials
Time of Update: 2020-11-26
BEIJING, June 6 (Xinhua Sun Zifa) China's Institute of Microbiology announced through the official network platform on the 6th, the new coronavirus all-human monoclonal antibody developed by the anti-epidemic science and technology team of the new application for clinical trials, 5 has been officially approved by the State Drug Administration, its Phase I clinical trials will be in healthy people for safety and dose testing.
-
Cell reveals that patients with COVID-19 asymptomatic or recovery periods have strong resistance
Time of Update: 2020-10-02
further analysis of early T-cell disorders in neocyto pneumonia, the researchers found that memory CD8-T cell high expression CD38 in patients with acute moderate and severe neocyctic pneumonia was positively associated with the number of asymptomatic days after infection, and negative correlation between the expression of CCR7 and CD45RA in SARS-CoV-2-specific CD8-T cells compared to recovery period and healthy control.
-
Moderna plans to offer the COVID-19 vaccine at a price of $50-$60 per course
Time of Update: 2020-08-05
previous lying: Moderna's COVID-19 candidate vaccine (mRNA-1273) induced a strong immune response in all subjects, in which anti-SARS-CoV-2 antibodies were induced and neutralized.
mRNA-1273 vaccine produces antibodies against the SARS-CoV-2 antist protein by stimulating the body.
-
Natno Biotechl: New technology for highly sensitive detection of COVID-19
Time of Update: 2020-07-31
27, 2020 // --- In a recent study published in the journal Nature Biotechnology, scientists from the National Duke University School of Medicine worked closely with the National Center for Infectious Diseases (NCID), the Singapore Institute of Molecular and Cell Biology (IMCB), to develop a new test kit, "sVNT." sVNT can detect the presence of functional neutralizing antibodies (NAb) in newly coronavirus-infected people, preventing the binding of the coronavirus stingin synthasi and angiotensin-converting enzyme 2 (ACE2) host receptor.
-
Cell: In the pandemic, the new coronavirus D614G is generally mutated, and the infection titer has increased by nearly 10 times
Time of Update: 2020-07-27
It was found that sars-cov-2 variant carrying spike protein d614g has become the most common strain in the global pandemic, with adaptability advantages and in many places There was a recurrence pattern.
-
SCIENCE: SARS-CoV-2 infected macaques are resistant to secondary infections, Qinchuan team reports
Time of Update: 2020-07-16
!---- The 2019 coronavirus disease (COVID-19) is a severe acute respiratory syndrome caused by coronavirus type 2 (SARS-CoV-2) infection and is now a global epidemic it is still unclear whether cured
-
bioRxiv: Research and development of neutralizing therapeutic antibodies that can neutralise both SARS-CoV-2 and SARS-CoV
Time of Update: 2020-06-25
, June 17, 2020 /PRNewswire/ -- The COVID-19 pandemic caused by the SARS-CoV-2 virus has created an unprecedented public health crisis There are currently no approved vaccines or treatments for COV
